These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11682218)

  • 1. Determination of verapamil in pharmaceutical formulations using atomic emission spectrometry.
    Khalil S; Kelzieh A
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):123-31. PubMed ID: 11682218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomic emission spectrometric determination of ephedrine, cinchonine, chlorpheniramine, atropine and diphenhydramine based on formation of ion associates with ammonium reineckate.
    Khalil S
    J Pharm Biomed Anal; 1999 Dec; 21(4):697-702. PubMed ID: 10701933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of lignocaine and amprolium in pharmaceutical formulations using AAS.
    El-Hawary WF
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):97-105. PubMed ID: 11682215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect atomic absorption spectrometric determination of pindolol, propranolol and levamisole hydrochlorides based on formation of ion associates with manganese thiocyanate and potassium ferricyanide.
    Khalil S; El-Rabiehi MM
    J Pharm Biomed Anal; 2000 Feb; 22(1):7-12. PubMed ID: 10727118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect atomic absorption spectrometric determination of pindolol, propranolol and levamisole hydrochlorides based on formation of ion-associates with ammonium reineckate and sodium cobaltinitrite.
    Khalil S; Borham N
    J Pharm Biomed Anal; 2000 Mar; 22(2):235-40. PubMed ID: 10719905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect atomic absorption determination of atropine, diphenhydramine, tolazoline, and levamisole based on formation of ion-associates with potassium tetraiodometrcurate.
    El Ries MA; Khalil S
    J Pharm Biomed Anal; 2001 Apr; 25(1):3-7. PubMed ID: 11274852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrofluorometric determination of verapamil hydrochloride in pharmaceutical preparations and human plasma using organized media: application to stability studies.
    Walash M; Belal F; El-Enany N; Abdelsalam A
    J AOAC Int; 2006; 89(6):1565-72. PubMed ID: 17225603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic analysis of verapamil and its application to determination in tablet dosage forms and to drug dissolution studies.
    Ozkan Y; Yilmaz N; Ozkan SA; Biryol I
    Farmaco; 2000 May; 55(5):376-82. PubMed ID: 10983283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New co-polymer zwitterionic matrices for sustained release of verapamil hydrochloride.
    Kostova B; Rachev D
    Acta Pharm; 2007 Dec; 57(4):429-39. PubMed ID: 18165187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomic absorption spectroscopic, conductometric and colorimetric methods for determination of some fluoroquinolone antibacterials using ammonium reineckate.
    Al-Ghannam SM
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Apr; 69(4):1188-94. PubMed ID: 17689288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a liquid chromatographic method for the determination of related substances in verapamil hydrochloride.
    Valvo L; Alimenti R; Alimonti S; Raimondi S; Foglietta F; Campana F
    J Pharm Biomed Anal; 1997 Apr; 15(7):989-96. PubMed ID: 9160266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of ambroxol hydrochloride in pure solutions and some of its pharmaceutical preparations under batch and FIA conditions.
    Abdel-Ghani NT; Hussein SH
    Farmaco; 2003 Aug; 58(8):581-9. PubMed ID: 12875889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil hydrochloride release characteristics from new copolymer zwitterionic matrix tablets.
    Kostova B; Kamenska E; Ivanov I; Momekov G; Rachev D; Georgiev G
    Pharm Dev Technol; 2008; 13(4):311-21. PubMed ID: 18649221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic study of CYP3A4 activity on verapamil by capillary electrophoresis.
    Zhang J; Thi Thanh Ha P; Lou Y; Hoogmartens J; Van Schepdael A
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):612-7. PubMed ID: 15905061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pKa determination of verapamil by liquid-liquid partition.
    Hasegawa J; Fujita T; Hayashi Y; Iwamoto K; Watanabe J
    J Pharm Sci; 1984 Apr; 73(4):442-5. PubMed ID: 6726625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexation of DTPA and EDTA with Cd
    Karak T; Paul RK; Das DK; Boruah RK
    Environ Monit Assess; 2016 Dec; 188(12):670. PubMed ID: 27848112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of heavy metal ions from aqueous solutions using carbon aerogel as an adsorbent.
    Meena AK; Mishra GK; Rai PK; Rajagopal C; Nagar PN
    J Hazard Mater; 2005 Jun; 122(1-2):161-70. PubMed ID: 15878798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAS and AES determination of furaltadone, methadone and trazodone in pharmaceutical formulations.
    Khalil S; El-Ries MA
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):117-22. PubMed ID: 11682217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrophotometric method for the determination of verapamil hydrochloride in pharmaceutical formulations using N-bromosuccinimide as oxidant.
    Rahman N; Hejaz Azmi SN
    Farmaco; 2004 Jul; 59(7):529-36. PubMed ID: 15231428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid HPLC assay for verapamil and its metabolites: use for application to in vitro studies.
    Fischer U; Wacke R; Stange J; Nitschke FP; Adam U; Drewelow B
    Pharmazie; 1996 Apr; 51(4):220-3. PubMed ID: 8628739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.